» Articles » PMID: 37417877

Extrinsic and Intrinsic Modulators of Inflammation-resolution Signaling in Heart Failure

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic and uncleared inflammation is the root cause of various cardiovascular diseases. Fundamentally, acute inflammation is supportive when overlapping with safe clearance of inflammation termed resolution; however, if the lifestyle-directed extrinsic factors such as diet, sleep, exercise, or physical activity are misaligned, that results in unresolved inflammation. Although genetics play a critical role in cardiovascular health, four extrinsic risk factors-unhealthy processed diet, sleep disruption or fragmentation, sedentary lifestyle, thereby, subsequent stress-have been identified as heterogeneous and polygenic triggers of heart failure (HF), which can result in several complications with indications of chronic inflammation. Extrinsic risk factors directly impact endogenous intrinsic factors, such as using fatty acids by immune-responsive enzymes [lipoxygenases (LOXs)/cyclooxygenases (COXs)/cytochromes-P450 (CYP450)] to form resolution mediators that activate specific resolution receptors. Thus, the balance of extrinsic factors such as diet, sleep, and physical activity feed-forward the coordination of intrinsic factors such as fatty acids-enzymes-bioactive lipid receptors that modulates the immune defense, metabolic health, inflammation-resolution signaling, and cardiac health. Future research on lifestyle- and aging-associated molecular patterns is warranted in the context of intrinsic and extrinsic factors, immune fitness, inflammation-resolution signaling, and cardiac health.

Citing Articles

Genetic deletion of 12/15 lipoxygenase delays vascular remodeling and limits cardiorenal dysfunction after pressure overload.

Lee D, Kain V, Wang D, Rokosh D, Prabhu S, Halade G J Mol Cell Cardiol Plus. 2025; 5():100046.

PMID: 39802176 PMC: 11708313. DOI: 10.1016/j.jmccpl.2023.100046.


Mendelian randomization of plasma lipidome, inflammatory proteome and heart failure.

Zheng Z, Tan X ESC Heart Fail. 2024; 11(6):4209-4221.

PMID: 39145416 PMC: 11631237. DOI: 10.1002/ehf2.14997.


Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19.

Owens C, Pinto C, Detwiler S, Olay L, Pinaffi-Langley A, Mukli P Brain Commun. 2024; 6(2):fcae080.

PMID: 38495306 PMC: 10943572. DOI: 10.1093/braincomms/fcae080.


The heart-bone connection: relationships between myocardial infarction and osteoporotic fracture.

Tjandra P, Ripplinger C, Christiansen B Am J Physiol Heart Circ Physiol. 2024; 326(3):H845-H856.

PMID: 38305753 PMC: 11062618. DOI: 10.1152/ajpheart.00576.2023.

References
1.
Kain V, Ingle K, Kachman M, Baum H, Shanmugam G, Rajasekaran N . Excess ω-6 fatty acids influx in aging drives metabolic dysregulation, electrocardiographic alterations, and low-grade chronic inflammation. Am J Physiol Heart Circ Physiol. 2017; 314(2):H160-H169. PMC: 5867649. DOI: 10.1152/ajpheart.00297.2017. View

2.
Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald J . D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J. 2013; 27(6):2220-32. PMC: 3659350. DOI: 10.1096/fj.12-225615. View

3.
Tourki B, Kain V, Shaikh S, Leroy X, Serhan C, Halade G . Deficit of resolution receptor magnifies inflammatory leukocyte directed cardiorenal and endothelial dysfunction with signs of cardiomyopathy of obesity. FASEB J. 2020; 34(8):10560-10573. PMC: 7704037. DOI: 10.1096/fj.202000495RR. View

4.
Lopez-Vicario C, Titos E, Walker M, Alcaraz-Quiles J, Casulleras M, Duran-Guell M . Leukocytes from obese individuals exhibit an impaired SPM signature. FASEB J. 2019; 33(6):7072-7083. DOI: 10.1096/fj.201802587R. View

5.
Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S . Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005; 201(5):713-22. PMC: 2212834. DOI: 10.1084/jem.20042031. View